Response, Resistance and Metastasis of Locally Advanced Breast Cancer (LABC, Stage 2B-3C) in a Multiethnic Cohort: A Phase II International Multicentric Study of Concurrent Paclitaxel and Radiation
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 30 May 2018
At a glance
- Drugs Paclitaxel (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 23 May 2018 Planned primary completion date changed from 1 Mar 2018 to 1 Jun 2019.
- 27 Dec 2017 Planned primary completion date changed from 1 Mar 2016 to 1 Mar 2018.